Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bertolaccini, M. L.
Right arrow Articles by Hughes, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bertolaccini, M. L.
Right arrow Articles by Hughes, G. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

The British Journal of Rheumatology, Vol 37, 1229-1232, Copyright © 1998 by British Society for Rheumatology


ORIGINAL PAPERS

Multiple antiphospholipid tests do not increase the diagnostic yield in antiphospholipid syndrome

ML Bertolaccini, B Roch, O Amengual, T Atsumi, MA Khamashta and GR Hughes
Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, London.

The family of antiphospholipid antibodies (aPL) includes a heterogeneous population of autoantibodies whose specificity is directed against not only phospholipids, but their complex with plasma proteins. Anticardiolipin antibodies (aCL) and lupus anticoagulant (LA) tests are widely performed to screen the aPL family which is associated with thrombotic complications in patients with systemic lupus erythematosus (SLE) or antiphospholipid syndrome (APS). The clinical significance of other aPL tests, including antibodies against phosphatidylserine (aPS), phosphatidylinositol (aPI), phosphatidic acid (aPA), phosphatidylcholine (aPC) and phosphatidylethanolamine (aPE), has not been established. The purpose of this study was to evaluate whether multiple aPL tests have enhanced diagnostic value for APS. We tested IgG/M/A aPS, aPI, aPA, aPC and aPE by ELISA using 10% bovine serum as blocking and sample diluent in 26 SLE patients with clinical manifestations of APS, but negative for both aCL and LA (Group 1). The results were compared with 32 SLE patients without any features of APS (Group 2) and 24 SLE patients with APS (aCL and/or LA positive) (Group 3). In Group 1, 1/26 (4%) was positive for IgA aPE, less frequent than in other groups, and none of the patients had any other aPL. In Group 2, 1/32 (3%) was positive for aPS, two (6%) for aPI, one (3%) for aPA and four (12.5%) for aPE. None was positive for aPC. In the third group, 13/24 (54%) were positive for aPS, 11 (46%) for aPI, 15 (63%) for aPA, four (17%) for aPC and seven (29%) for aPE. Since aPE was found in some patients, we extended the study, including 207 SLE patients, and tested aPE. IgG/M/A aPE was found in six (3%), 10(5%) and 21 (10%), respectively, but no association was found between aPE and any clinical features of APS. This study suggests that screening by multiple aPL tests does not increase the diagnostic yield in APS.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CLIN APPL THROMB HEMOSTHome page
M. A. Ozturk, I. C. Haznedaroglu, M. Turgut, and H. Goker
Current Debates in Antiphospholipid Syndrome: The Acquired Antibody-Mediated Thrombophilia
Clinical and Applied Thrombosis/Hemostasis, April 1, 2004; 10(2): 89 - 126.
[Abstract] [PDF]


Home page
Ann Rheum DisHome page
G R V Hughes and M A Khamashta
Seronegative antiphospholipid syndrome
Ann Rheum Dis, December 1, 2003; 62(12): 1127 - 1127.
[Full Text] [PDF]


Home page
LupusHome page
D M Levy, M P Massicotte, E Harvey, D Hebert, and E D Silverman
Thromboembolism in paediatric lupus patients
Lupus, October 1, 2003; 12(10): 741 - 746.
[Abstract] [PDF]


Home page
Ann Rheum DisHome page
D Caccavo, F Del Porto, P Garzia, A P Mitterhofer, S Galluzzo, A Rigon, M Vadacca, M F Navajas, A Amoroso, and A Afeltra
Raynaud's phenomenon and antiphospholipid antibodies in systemic lupus erythematosus: is there an association?
Ann Rheum Dis, October 1, 2003; 62(10): 1003 - 1005.
[Abstract] [Full Text]


Home page
Obstet GynecolHome page
D. W. Branch and M. A. Khamashta
Antiphospholipid Syndrome: Obstetric Diagnosis, Management, and Controversies
Obstet. Gynecol., June 1, 2003; 101(6): 1333 - 1344.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J.-C. Wasmuth, D. Oliver y Minarro, A. Homrighausen, L. Leifeld, J. K. Rockstroh, T. Sauerbruch, and U. Spengler
Phospholipid Autoantibodies and the Antiphospholipid Antibody Syndrome: Diagnostic Accuracy of 23 Methods Studied by Variation in ROC Curves with Number of Clinical Manifestations
Clin. Chem., July 1, 2002; 48(7): 1004 - 1010.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
E. L. Radway-Bright, C. T. Ravirajan, and D. A. Isenberg
The prevalence of antibodies to anionic phospholipids in patients with the primary antiphospholipid syndrome, systemic lupus erythematosus and their relatives and spouses
Rheumatology, April 1, 2000; 39(4): 427 - 431.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.